Ailon Invest

Ailon Invest is an Israeli-based entity that operates at the intersection of financial services and biotechnology development. The company is recognized as an originator for several pharmaceutical programs, most notably in collaboration with YD Global Life Science. Its pipeline includes small molecule inhibitors targeting c-Kit for ophthalmic and oncological indications, as well as treatments for respiratory diseases like idiopathic pulmonary fibrosis. While also associated with financial consulting and lending services in Israel, its role in the life sciences sector involves the early-stage development and origination of therapeutic assets.